Introduction
Cancer therapy, traumatic blood loss and acute infection can all result in the depletion of mature blood cells, leading to immunodeficiency, anemia and other lifethreatening complications. The hematopoietic stem and progenitor cell compartment responds rapidly to such stress by increasing blood cell production through a process known as 'emergency hematopoiesis'. Once the mature blood cell pools have been replenished hematopoiesis returns to homeostasis 1, 2 .
Apoptosis is a form of programmed cell death that plays a prominent role in the hematopoietic system. Insufficient apoptosis causes an increase in hematopoietic cells, which can be a forerunner of leukemia or lymphoma, whereas excessive apoptosis causes immunodeficiency, anemia and thrombocytopenia 3 . The BCL-2 protein family members are critical regulators of apoptosis. The pro-survival BCL-2-like members (e.g. BCL-2, BCL-XL, MCL-1) are required for cell survival. The multi-BH domain pro-apoptotic members BAX and BAK unleash the demolition phase of apoptosis and the pro-apoptotic BH3-only proteins (e.g. BIM, PUMA) are critical for initiation of apoptosis signaling 4, 5 . Apoptosis is initiated when BH3-only proteins are transcriptionally or post-transcriptionally up-regulated to activate BAX/BAK, either through direct interaction or indirectly by unleashing them from their restraint by the pro-survival BCL-2-like proteins 4, 5 . Members of the BCL-2 family regulate apoptosis in a cell type and apoptotic stimulus specific manner. For example, PUMA is required for DNA damage-induced apoptosis 6-8 , whereas BIM is critical for apoptosis following cytokine withdrawal 9 . Pro-survival BCL-XL is essential for survival of erythroid progenitors 10 whereas MCL-1 maintains numerous cell types, including many hematopoietic cell subsets [11] [12] [13] [14] [15] .
Little is known about the roles of the different BCL-2 family members in the control of the survival of stem/progenitor cells during emergency hematopoiesis, most notably whether changes in the level of these proteins may influence chemotherapyassociated toxicity or the likelihood of successful bone marrow transplantation.
These are important issues because inhibitors of pro-survival BCL-2 family members, the BH3 mimetics navitoclax/ABT-263 and are 
Treatment with 5-fluorouracil or γ-irradiation
Mice (10-12 weeks old, male and female) were injected once intraperitoneally (i.p.) with either 150 mg/kg 5-fluorouracil (5-FU) or vehicle (PBS), or were subjected to 8
Gy γ-irradiation. Mandible bleeds were taken for a hemogram before treatment commenced. Further mandible bleeds were taken on days 4, 7, 10, 14 and 21 to monitor recuperation of the hematopoietic system. Blood composition was analyzed using the ADVIA blood analyzer and flow cytometric analysis. For the purpose of analyzing leukocyte numbers, erythroid cells were removed using red blood cell removal buffer. The experiments were concluded on day 21 by sacrificing the animals and harvesting organ samples for histological analysis. Mice that presented with signs of failure of the hematopoietic system (as judged by an experienced animal technician, blinded to the treatment and genotype of the mice), such as weight loss and anemia before day-21 were sacrificed and organs taken for histological analysis.
Flow cytometric analysis and cell sorting
Thymus, spleen and bone marrow cells were harvested from reconstituted mice and single cell suspensions prepared. Cells were counted using Casy®Cell Counter (Schaefe System GmbH). Retro-orbital bleeds were taken for a hemogram (ADVIA). MCL-1 intracellular staining was performed using the BD Cytofix/Cytoperm Kit (BD Biosciences) with anti- ) directly conjugated to Alexa Fluor 647 (Life Technologies). LSK cells were sorted in a BD Influx (BD Biosciences) using the antibody staining protocol described above. The cells were cultured in medium supplemented with SCF (100 ng/mL), IL-6 (10 ng/mL), TPO (50 ng/mL) and Flt3 (10 ng/mL) overnight and then γ-irradiated (4 Gy) or maintained in medium alone. Cell viability was monitored by flow cytometric analysis over 24 h by staining with Annexin V and PI. Annexin V -PI -cells were deemed viable.
Statistical analysis
In all cases sample and mouse numbers were chosen based on previous experience with mice deficient for various BCL-2 family members. All data points were included in final analysis, without exclusions. No randomization methods were performed for sample -treatment allocations. All animal survival experiments were conducted in a blinded manner with 'sick' mice identified by an experienced mouse technician blinded to the treatment (Figures 1,2,4) ; or to the genotype, in the case of acute Mcl-1 deletion experiments ( Figure 5 ).
Kaplan-Meier mouse survival curves were generated in GraphPad Prism (GraphPad Software Inc) for the 5-fluorouracil treatment, γ-irradiation and acute Mcl-1 deletion experiments. Mouse cohorts were compared using the log-rank Mantel-Cox test. Pvalues (unpaired, equal variance, two-sided) of less than 0.05 were considered significant.
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Blood and organ cell counts were plotted and analyzed with GraphPad Prism using two-tailed student's t-test comparing two groups with each other. We found no evidence for deviation of the data points from a normal distribution nor for differences in variance between groups under analysis. Error bars represent standard error of mean (±SEM). Bcl-x +/-mice exhibited robust recovery ( Fig. 1 and Supplementary Fig. 1 Fig. 1e and Supplementary Fig. 1 ).
Results

MCL
Flow cytometric analysis revealed comparable reductions in myeloid, B and T cell numbers in the peripheral blood of 5-FU treated mice of all genotypes (Supplementary Fig. 2 ). Leukocyte subset analysis of the few surviving 5-FU- Supplementary Fig. 3 ), these results demonstrate that MCL-1 is dose-limiting for recovery from 5-FU-induced myelo-ablation. (Fig. 2b) . These results confirm that MCL-1 is critical for the recovery of the hematopoietic system after DNA damage-induced cytopenia.
Analysis by flow cytometry of bone marrow Lineage -Sca-1 + c-KIT
stem/progenitor cells revealed reduced expression of MCL-1 at the protein level in
Mcl-1 +/-mice relative to wild-type mice, while LSK numbers were found to be normal ( Supplementary Fig. 4a,b) . Interestingly, isolated Mcl-1 +/-and wild-type LSK cells exhibited similar survival in vitro following γ-irradiation (Supplementary Fig. 4c ).
This suggests that the inability of the Mcl-1 +/-mice to recover from myelotoxic challenge is not due to hyper-sensitivity of their stem cells to DNA damage but must rather be due to increased apoptosis of progenitor cells in response to the stresses imposed by mobilization and consequently increased proliferation during emergency hematopoiesis.
Mcl-1 haplo-insufficiency impairs hematopoietic reconstitution after bone marrow transplantation
We next compared Mcl-1 +/-, Bcl-x +/-and wild-type bone marrow HSCs in a competitive setting over two rounds of transplantation: primary reconstitution (R1), and secondary reconstitution (R2) (Fig. 3a) . Lethally-irradiated (2 x 5.5 Gy) C57BL/6-Ly5.1 recipient mice were transplanted with either bone marrow cells than wild-type control cells were required (even in the absence of competitor cells) to achieve robust reconstitution of lethally-irradiated mice (Fig. 3f) .
Interestingly, Mcl-1 +/-stem/progenitor (LSK) cells were able to home to the bone marrow as efficiently as wild-type LSK cells (Supplementary Fig. 6 ). These results demonstrate that loss of one Mcl-1 allele severely impairs the ability of hematopoietic stem/progenitor cells to achieve reconstitution of the hematopoietic system in transplant recipients. Fig. 4c and Supplementary Fig. 9 ). Loss of both alleles of Bim or Puma was able to completely rescue the defects caused by haplo-insufficiency of Mcl-1 during the first round of reconstitution (R1) ( Fig. 4c and Supplementary Fig. 9 ). However, only complete loss of Puma was able to restore the serial repopulating capacity of the
Mcl-1 +/-bone marrow cells over two rounds of transplantation (R1 and R2) ( Fig. 4c and Supplementary Fig. 9 ). These results show that the critical function of MCL-1 in recovery of the hematopoietic system from stress is to restrain pro-apoptotic PUMA and (to a lesser extent) BIM. . In order to circumvent non-hematopoietic effects of MCL-1 deletion, we generated chimeric mice in which only the hematopoietic system was of the genotype of interest whereas all other tissues were wild-type.
Eight weeks following reconstitution, Mcl-1 deletion was induced in hematopoietic cells by administration of tamoxifen. As expected, the majority of mice reconstituted (Fig. 5b,c) , indicating that they had better survival than the Mcl-1
Discussion
Using experimental models of hematopoietic recovery that mimic DNA damage inducing cancer therapy and bone marrow transplantation, we investigated the role of BCL-2 family members in the control of stem/progenitor cell survival. In particular, we determined their importance during the rebound phase following myelo-toxic challenge with clinically relevant anti-cancer therapeutics (5-FU treatment or γ-1 3 irradiation) and in the burst of donor-derived stem/progenitor cell proliferation required to achieve stable reconstitution in myelo-ablated transplant recipients. We found that MCL-1 was essential to countermand stress-induced activation of PUMA (and to a lesser extent BIM) with consequent apoptosis induction (Fig. 6) . 6 . For personal use only. on May 2, 2017. by guest www.bloodjournal.org From
